Cargando…
Metformin for the treatment of antipsychotic-induced metabolic disturbances in people with intellectual and developmental disabilities
Autores principales: | Stogios, Nicolette, Hahn, Margaret K., Lunsky, Yona, Desarkar, Pushpal, Agarwal, Sri Mahavir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
CMA Impact Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10019321/ https://www.ncbi.nlm.nih.gov/pubmed/36918196 http://dx.doi.org/10.1503/jpn.220200 |
Ejemplares similares
-
Favourable cognitive changes observed with metabolic improvements in a patient with severe mental illness
por: van Reekum, Emma A, et al.
Publicado: (2023) -
Population pharmacokinetics and dosing of long-acting injectable antipsychotics
por: Kim, David D., et al.
Publicado: (2021) -
Atypical antipsychotics, dystonia, and psychotic depression: old solutions for new problems
por: Gazzellone, Matthew J., et al.
Publicado: (2022) -
The antipsychotic potential of cannabidiol: clinical implications for patients with psychosis and comorbid cannabis use disorder
por: Garel, Nicolas, et al.
Publicado: (2021) -
Elevated clozapine levels and toxic effects after SARS-CoV-2 vaccination
por: Thompson, Deborah, et al.
Publicado: (2021)